Background {#Sec1}
==========

Tick-borne encephalitis (TBE) is a severe neurological illness caused by tick-borne encephalitis virus (TBEV). TBEV is a neurotropic, positive-sense RNA virus that belongs to the genus *Flavivirus*, family *Flaviviridae*. TBEV infection can lead to a variety of clinical manifestations ranging from slight fever to severe neurological illness. Infections with TBEV may result in encephalitis, meningitis and haemorrhagic fevers with high mortality rates \[[@CR1]\].

TBEV occurs in forest and forest-steppe zones in the territory of central Europe, the Baltic and Scandinavian countries, and the Russian Federation. In Russia, TBE is endemic from Kaliningrad to Vladivostok \[[@CR2], [@CR3]\]. Three different subtypes of TBEV have been recognized (European, Siberian, and Far Eastern), which are associated with different disease severity \[[@CR3]\].

From 10,000 to 15,000 clinical cases are registered annually in Europe and Asia, \[[@CR4]\]. The incidence of TBE in all endemic regions of Europe has increased by almost 400% in the last 30 years. Thus, TBE has become a growing public health challenge in Europe and some other parts of the world \[[@CR3]\].

The spectrum of clinical presentations ranges from simple fever to severe encephalitis with or without myelitis. Infection may result in death (0.5--2.0%, case fatality rate possibly higher for the Siberian subtype) or long-term neurological sequelae (up to 58%, according to the World Health Organization) \[[@CR4]\]. Although effective vaccines against TBE are available, and are on the market since the 1980s, today there is no specific treatment for infection \[[@CR5], [@CR6]\].

Risk factors of the appearance of severe forms of tick-borne encephalitis are poorly understood. Severe forms of the disease can arise both as a result of weakening of antiviral immunity (that leads to an increase in the amount of virions and affection of larger amount of host cells) and due to excessive host immune response \[[@CR7]\]. Convincing evidences support the hypothesis that genetic factors may contribute to susceptibility or resistance to flaviviruses \[[@CR8]--[@CR11]\]. Nevertheless, by now, only few studies have been done on the genetic predisposition to severe forms of TBE.

It has been shown in the Russian population that five SNPs in *OAS2* and *OAS3* genes, as well as two SNPs in *IFNL3/IL28B* gene and polymorphisms in the *TLR3, CD209*, and *IL10* genes were associated with predisposition to severe forms of tick-borne encephalitis \[[@CR12]--[@CR15]\]. Polymorphisms in chemokine receptor 5 (*CCR5*) and toll-like receptor 3 (*TLR3*) genes were found to be a risk factors for clinical tick-borne encephalitis in the Lithuanian population \[[@CR16]--[@CR18]\].

Evidence of genetic factors predisposing to diseases caused by TBEV and other closely related flaviviruses (West Nile virus, dengue virus, yellow fever virus, etc.) has been summarized in recent reviews \[[@CR10], [@CR19]--[@CR22]\]. In all cases described above the estimation of the genetic risk of susceptibility to TBE relied on association studies, in which frequencies of candidate gene variants were compared in patients and healthy controls. We did not find any scientific reports based on high-throughput DNA sequencing or high-performance genotyping of samples from TBEV infected patients in available resources.

Like other Flaviviruses, TBEV possesses a positive sense RNA genome that encodes a single polyprotein, which is co- and posttranslationally processed into three structural proteins (Capsid, prM, and Envelope) and seven non-structural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B, and NS5) \[[@CR23]--[@CR25]\]. According to the 10th Online Report of the International Committee on Taxonomy of Viruses (ICTV, [www.ictvonline.org](http://www.ictvonline.org)), the genus *Flavivirus* includes more than 60 virus species of which 40 are known to cause disease in humans \[[https://talk.ictvonline.org/ictv-reports/ictv_online_report/](https://talk.ictvonline.org/ictv-reports/ictv_online_report)\]. Japanese encephalitis virus, dengue virus, yellow fever virus, West Nile virus, and Zika virus are among the most well-known human pathogens from *Flavivirus* genus \[[@CR26]\]. The most closely related viruses from the Tick-borne encephalitis virus serocomplex are Omsk hemorrhagic fever virus, Louping ill virus, and Langat virus \[<https://talk.ictvonline.org/ictv-reports/ictv_online_report/positive-sense-rna-viruses/w/flaviviridae>\].

At present diverse screening techniques have been applied providing unbiased data on host-pathogen interactions during viral infection. The growing number of studies provided a wealth of information regarding viruses from the *Flaviviridae* family, including screening of the host response to such closely related viral species as West Nile virus \[[@CR27]\], and Langat virus \[[@CR28]\]. Genome-wide association study aimed at the identification of the susceptibility loci for dengue shock syndrome (caused by the dengue virus) was performed \[[@CR29]\].

Despite the enormous value of data obtained for related viral species (West Nile, dengue, Langat viruses) there is a gap in the knowledge about critical contact points between TBEV and host cells (from the human or closely related mammalian organisms). Evidences exist that each viral species interferes with the unique repertoire of host factors to promote infection \[[@CR30]--[@CR32]\]. Additionally, each viral species has developed its own mechanisms to avoid the host immune response \[[@CR33]--[@CR35]\]. Thus, any piece of evidence of involvement of a gene or protein in response to TBEV infection may be valuable. Compiling data on genes involved in response to TBEV infection and integrating them in online resource may facilitate identification of potential drug targets and development of novel strategies for treating infection caused by TBEV.

The objectives of this study were: (1) to compile a catalog of human genes involved in response to TBEV infection; (2) to construct and analyze the network formed by pairwise physical interactions between genes/proteins from the catalog and their pairwise interactions with TBEV; (3) to rank genes according to the number of neighbors in the network.

Methods {#Sec2}
=======

Compiling candidate genes and assigning them to functional categories {#Sec3}
---------------------------------------------------------------------

Firstly, candidate genes were selected using a domain-specific search engine for medical information Coremine Medical ([www.coremine.com](http://www.coremine.com)), which offers networks involving genes and proteins related to query term(s). *Tick-Borne Encephalitis' (disease)* was used as a search term. For each gene identified from the Coremine Medical tool, we performed manual literature mining to find research articles confirming involvement of genes in response to TBEV infection.

We revealed that a number of publications reviewed at the first step presented evidences confirming involvement of additional other genes (not found by Coremine Medical) in response to TBEV infection.

For this reason, online searches were then undertaken (PubMed), using the following combinations of the key words: (1) (*TBEV* OR *tick-borne encephalitis*) AND (*PPI* OR *Physical interactions*); (2) (*TBEV* OR *tick-borne encephalitis*) AND *expression*; (3) (*TBEV* OR *tick-borne encephalitis*) AND *association*; (4) (*TBEV* OR *tick-borne encephalitis*) AND *Knockout*. This yielded a collection of research articles describing involvement of human genes/proteins (or genes/proteins from other mammalian species) in response to TBEV. In accordance with the type of evidence found in the article each gene/protein was assigned to a specific category (dataset). The names of datasets and their descriptions are presented in the Table [1](#Tab1){ref-type="table"}.Table 1Functional groups of genes/proteins (datasets) that were included into the catalog of genes involved in response to TBEV infectionDataset (type of evidence)Description of the datasetNumber of genesNumber of publications1.Physical interaction\
(Additional file [1](#MOESM1){ref-type="media"}: Table S1)Genes encoding proteins that had direct physical interactions with TBE viral particle, TBEV proteins or RNA.51132.Up- or down-regulated\
(Additional file [1](#MOESM1){ref-type="media"}: Table S2)Genes encoding mRNAs (or proteins) that were up- or down-regulated in response to TBEV infection^a^76363.Allelic variant\
(Additional file [1](#MOESM1){ref-type="media"}: Table S3)Allelic variant in this gene was associated with susceptibility or resistance to TBEV infection^b^964.Increased/attenuated antiviral activity\
(Additional file [1](#MOESM1){ref-type="media"}: Table S4)These proteins were required for inhibitory effect of other proteins against TBEV or attenuated its antiviral activity665.Knockout\
(Additional file [1](#MOESM1){ref-type="media"}: Table S5)Knockout of these genes in mice increased mortality rates or affected the other clinical manifestations of the disease64All_catalog\
(Additional file [1](#MOESM1){ref-type="media"}: Table S6)The catalog of human genes involved in response to TBEV infection.14053^a^If there was evidence that the level of an active form of the protein changed in response to TBEV infection, the gene encoding such protein was also included into this dataset^b^That meant that clinical severity of disease or some immunological parameters in patients with TBE were associated with one of allelic variants

To create a catalog of genes involved in response to TBEV infection we merged all datasets and removed duplicates.

Network construction {#Sec4}
--------------------

Using data extracted from the literature, the following six types of pairwise interaction were generated, involving genes or proteins from the catalog: (1) physical interactions between viral proteins or RNA or the whole TBEV particle and host proteins (*PIs involving TBEV*); (2) the effects of TBE viral particle or viral RNA or TBEV proteins on the expression levels of the host mRNA or proteins (*Up- or down-regulation*); (3) associations of allelic variants in human genes with susceptibility or resistance to TBEV infection (*Associations)*; (4) physical interactions with proteins from the first three groups named above affecting the biological response to TBEV (*PPIs affecting response)*; (5) indirect interaction with proteins from the first three groups named above within the same signaling pathway affecting the biological response to TBEV (*Interaction within pathway)*; (6) the effect of a gene knockout on the survival time after TBEV infection (*Knockout).* The description of pairwise interactions is presented in Table [2](#Tab2){ref-type="table"}.Table 2Pairwise interactions in the network involving genes/proteins from the catalogShort name of the interactionDescriptionNode 1Node 2Data sourceNumber of interactions in the network1.PIs involving TBEVPhysical interactions between viral proteins or RNA or the whole TBEV particle and host proteinsThe whole TBEV particle, or viral proteins or viral RNAHuman gene/protein from the catalogResearch articles512.Up- or down-regulationThe effects of the whole TBEV particle or viral RNA or TBEV proteins on the expression levels of the host mRNA or proteinsThe whole TBEV particle, or viral proteins or viral RNAHuman gene/protein from the catalogResearch articles763.AssociationsAssociations of allelic variants in human genes with susceptibility or resistance to TBEV infectionThe object TBEV susceptibility/resistanceHuman gene/protein from the catalogResearch articles94.PPIs affecting responsePhysical interactions with proteins from the catalog affecting the biological response to TBEVHuman gene/protein from the catalogHuman gene/protein from the catalogResearch articles45.Interaction within pathwayIndirect interaction with proteins from the catalog within the same signaling pathway affecting the biological response to TBEVHuman gene/protein from the catalogHuman gene/protein from the catalogResearch articles26.KnockoutThe effect of a gene knockout on the survival time after TBEV infection or disease manifestationsThe object KnockoutHuman gene/protein from the catalogResearch articles67.PPI_STRING\
(Additional file [1](#MOESM1){ref-type="media"}: Table S7)Physical interactions between genes/proteins from the catalog obtained from STRING and passed manual verificationHuman gene/protein from the catalogHuman gene/protein from the catalogSTRING and Research articles25

We also employed the STRING (Search Tool for the Retrieval of Interacting Genes/Proteins) \[[@CR36]\] to identify pairwise physical interactions between all human proteins encoded by genes compiled in the catalog. We considered physical interactions with STRING scores greater than 0.4. Beyond that all pairwise physical interactions obtained from STRING were checked manually and only those interactions were selected which were described in research articles and were revealed in human or rodents. Thus, we obtained data on the seventh type of pairwise interactions *PPI_STRING* (Table [2](#Tab2){ref-type="table"}). Data on interactions *PPI_STRING* are presented in the Additional file [1](#MOESM1){ref-type="media"}: Table S7.

To construct a network integrating genes/proteins involved in response to TBEV infection, data on pairwise relationships of all types described above (Table [2](#Tab2){ref-type="table"}) were imported into Cytoscape \[[@CR37]\].

The following data had been imported into Cytoscape as attributes of nodes and edges: (1) the functional category of each gene/protein (the datasets, described in the Table [1](#Tab1){ref-type="table"}); (2) the type of pairwise interactions between objects in the network (*physical interactions, up- or down-regulation, Associations*, etc., described in the Table [2](#Tab2){ref-type="table"}). These attributes of nodes and edges were used to arrange the visualization style.

Results {#Sec5}
=======

The catalog of human genes involved in response to tick-borne encephalitis virus infection {#Sec6}
------------------------------------------------------------------------------------------

By systematic review and curation of multiple lines of evidence we created a catalog of human genes involved in response to TBEV infection. Among them 44 genes were initially obtained from Coremine Medical tool and the other 96 genes were found in scientific publications manually. As a result, we selected 140 candidate genes (Table [1](#Tab1){ref-type="table"}, and Additional file [1](#MOESM1){ref-type="media"}: Table S6). The number of genes classified into functional categories (datasets) according to five types of evidence listed in the [Compiling candidate genes and assigning them to functional categories](#Sec3){ref-type="sec"} section are presented in the Table [1](#Tab1){ref-type="table"}.

*The physical interaction* dataset included 51 genes (Additional file [1](#MOESM1){ref-type="media"}: Table S1). Three proteins in the *Physical interaction* dataset (laminin subunit beta 1, extracellular matrix protein encoded by *LAMB1,* integrin subunit alpha 3 encoded by *ITGA3*, and ribosomal protein SA (also known as 67 kD laminin receptor) encoded by *RPSA*) were revealed to have interactions with the whole TBE viral particle \[[@CR38]\]. Two proteins (TIA1, cytotoxic granule associated RNA binding protein (encoded by *TIA1*), and TIAL1 cytotoxic granule associated RNA binding protein like 1 (encoded by *TIAL1*)) were found to interact with the viral RNA \[[@CR39]\]. In addition, one protein (immunoglobulin-like cell surface protein ILT7 encoded by *LILRA4*) interacted with inactivated whole virus vaccine against TBE (FSME-IMMUN) \[[@CR40]\]. The largest portion of proteins (47 out of 51) was found to interact with the individual viral proteins (prM, NS5, and E). Moreover, 44 out of these 47 proteins interacted with the viral protein NS5. Most proteins interacting physically with TBEV NS5 protein (33 out of 47), were compiled from one research article based on data obtained from a high-throughput yeast two-hybrid screen \[[@CR30]\].

*Up- or down-regulated* dataset included 76 genes (Additional file [1](#MOESM1){ref-type="media"}: Table S2). For 40 genes from *Up- or down-regulated* dataset we found expression data at the level of mRNA, and for 49 genes we found that the level of encoded proteins or its active forms increased or decreased in response to TBEV infection. Besides, 39 out of 76 genes/proteins from *Up- or down-regulated* dataset were revealed from in vivo studies comparing TBEV-infected and uninfected human sera or other human biological samples (plasma, cerebrospinal fluid (CSF), etc.) (Table [3](#Tab3){ref-type="table"}). The levels of eight, ten and two proteins were found to be up- or down-regulated in the sera, or plasma, or blood of infected patients. The levels of ten and two proteins were changed in CSF or liquor of infected patients. In addition, ten and 13 proteins changed their levels in NK cells and T cells of TBEV-infected patients.Table 3Genes/proteins from *Up- or down-regulated* dataset that were revealed from studies comparing TBEV-infected and uninfected human sera or other biological samplesBiological sampleGenesReferencesSerumICAM2\[[@CR87]\]MMP9\[[@CR88]\]ICAM3, ICAM1\[[@CR89]\]IL10, IFNB1\[[@CR46]\]CXCL10, CXCL13\[[@CR90]\]PlasmaIFNG, TNF, IL6, CXCL8, IL2, IL12A, IL12B, IL15, IL18, IFNA1\[[@CR91]\]BloodLTF\[[@CR92]\]GSN\[[@CR93]\]CSFIFNL3, IL10, IFNB1\[[@CR46]\]ICAM1\[[@CR87], [@CR89], [@CR94]\]ICAM2\[[@CR89]\]ICAM3\[[@CR87], [@CR89]\]CXCL10, CXCL11, CXCL12, CXCL13\[[@CR90]\]LiquorA2M\[[@CR67]\]LTF\[[@CR92]\]NK cellsMKI67, BCL2, PRF1, GZMB, IL2, IL12A, IL12B, IL15, IL18, IFNA1\[[@CR91]\]T cellsPRF1, PDCD1, BCL2, GZMB, IL7R, CD27, TBX21, EOMES, IKZF2\[[@CR95]\]IL5\[[@CR96]\]IFNG\[[@CR96], [@CR97]\]IL2, TBX21\[[@CR97]\]

*Allelic variant* dataset included nine genes (Additional file [1](#MOESM1){ref-type="media"}: Table S3). The clinical severity of disease or some immunological parameters in patients with TBE were associated with one of allelic variants in these genes. Data was collected on 12 SNP and one 32-base-pair deletion (CCR5delta32) located not only in the bodies of these genes but also in their 5′- or 3′-flanking regions, as it is well known that upstream and downstream gene regions are very important for transcriptional regulation \[[@CR41]--[@CR45]\].

Nine out of 13 SNPs (in *TLR3, CD209, OAS2, OAS3, IFNL3/IL28B,* and *IL10*) were studied in Russian population from Novosibirsk \[[@CR12]--[@CR15]\]. One SNP (rs3775291 in the 4th exon of *TLR3*) and one 32-base-pair deletion (rs333) in *CCR5* coding region (CCR5delta32) were studied in Lithuanian population \[[@CR18]\]. In addition, two SNPs (rs12979860 in the first intron of *IFNL4* and rs287886 the first intron of *ARID1B*) were studied in the Polish population \[[@CR46]\].

It should be noted that according to \[[@CR46]\], rs12979860 locus (located in the first intron of *IFNL4* and upstream of IFNL3) was associated with *IFNL3* expression. The second polymorphic locus rs287886 described in this report was found to be associated with *IL10* expression \[[@CR46]\]. These authors annotated the second polymorphic locus (rs287886) to *CD209* gene located on 19 chromosome. However, according to dbSNP, rs287886 is located in the first intron of *ARID1B* gene mapped to the 6-th chromosome. Thus, we included *IFNL3* and *IL10* into the *Up- or down-regulated* dataset. *IFNL4* and *ARID1B* were included into *Allelic variant* dataset. *CD209* gene was also included into the *Allelic variant* dataset based on data reported in \[[@CR13]\]. In this study it was revealed that the rs2287886 SNP in the *CD209* promoter region (but not rs287886 that was annotated to *CD209* gene by \[[@CR46]\]), was associated with predisposition to severe forms of TBE in the Russian population.

*Increases/attenuates antiviral activity* dataset included six genes/proteins (Additional file [1](#MOESM1){ref-type="media"}: Table S4). Four out of six proteins (encoded by *RAC1, ARHGEF7, CIAO1, ERN1*) exerted activation or attenuation via direct physical interactions with the other proteins \[[@CR47]--[@CR49]\]. The other two proteins (encoded by *S1PR4* and *PEPD*) collaborated with other proteins with well-known antiviral activity indirectly, being involved in the same signaling pathway \[[@CR40], [@CR50]\].

The *Knockout* dataset included six genes/proteins (Additional file [1](#MOESM1){ref-type="media"}: Table S5). Knockout of these genes in mice (1) increased mortality rates (*MAVS, TNF*) \[[@CR51], [@CR52]\]; (2) delayed the appearance of neurological signs of disease (*CD8A*) \[[@CR53]\]; (3) affected (increased or decreased) TBEV extracellular infectivity (*TIA1, TIAL1*) \[[@CR39]\].

To determine the total number of genes involved in response to TBEV infection, we merged all gene sets. With duplicates removed, a list comprising 140 unique genes was obtained (Table [1](#Tab1){ref-type="table"} and Additional file [1](#MOESM1){ref-type="media"}: Table S6).

The TBEVHostDB web resource {#Sec7}
---------------------------

To provide access to genes from the catalog, the TBEVhostDB web resource ([http://icg.nsc.ru/TBEVHostDB/](http://icg.nsc.ru/TBEVHostDB)) was created. In addition to the full list of genes, TBEVhostDB includes five lists of functional groups of genes that were described above (Sections [Compiling candidate genes and assigning them to functional categories](#Sec3){ref-type="sec"} and [The catalog of human genes involved in response to tick-borne encephalitis virus infection](#Sec6){ref-type="sec"}, and Table [1](#Tab1){ref-type="table"}). References to scientific publications and active links to NCBI resources (EntrezGene, PubMed, dbSNP) are given. In addition, some experimental details (host organism, method (in vivo/in vitro), TBEV strain (if available), etc.) are also presented in TBEVhostDB.

Network formed by pairwise interactions between genes/proteins {#Sec8}
--------------------------------------------------------------

To visualize pairwise interactions between genes/proteins from the TBEVHostDB, a network presenting data on interactions extracted from the literature and the STRING database was reconstructed. We classified pairwise interactions extracted from scientific publications into six categories (types) that were described previously in the section [Network construction](#Sec4){ref-type="sec"}. The seventh category included direct physical interactions between human proteins that were obtained from STRING and that passed a manual verification. According to STRING, 39 proteins/genes from the catalog were involved in pairwise physical interactions with each other (Additional file [1](#MOESM1){ref-type="media"}: Table S7). The numbers of interactions of each type are presented in the Table [2](#Tab2){ref-type="table"}. All data was uploaded into Cytoscape \[[@CR37]\]. Thus, a network comprising pairwise interactions involving TBEV (or viral RNA and protein) and 140 human genes/proteins from the TBEVHostDB was constructed (Fig. [1](#Fig1){ref-type="fig"}). About 30 % of genes from the network (39 out of 140, in the Fig. [1](#Fig1){ref-type="fig"} these gene names are shown in blue) were revealed from studies comparing TBEV-infected and uninfected human sera or other human biological samples (presented in Table [3](#Tab3){ref-type="table"}). The levels of 20 proteins (denoted by hexagons) were found to be changed in TBEV-infected human sera (or plasma and blood of TBEV-infected patients).Fig. 1The network presenting data on pairwise interactions involving TBEV (or viral RNA and protein) and 140 human genes/proteins from the TBEVHostDB. The descriptions of genes/proteins datasets were given in Table [1](#Tab1){ref-type="table"}. The descriptions of interactions were given in Table [2](#Tab2){ref-type="table"}. The names of 39 genes/proteins from *up- or down-regulated* dataset that were revealed from studies comparing TBEV-infected and uninfected human sera or other human biological samples (presented in Table [3](#Tab3){ref-type="table"}) are shown in blue. Hexagons denote 20 proteins revealed to be up- or down-regulated in human sera, plasma, and blood

The data presented in a visualization-ready format that allows the direct re-creation of the interactive version of the Fig. [1](#Fig1){ref-type="fig"} with Cytoscape is presented in the Additional file [2](#MOESM2){ref-type="media"}.

The ranking of genes in the network of pairwise interactions involving TBEV and 140 human genes/proteins from the TBEVHostDB {#Sec9}
----------------------------------------------------------------------------------------------------------------------------

We ranked human genes/proteins in the network according to the number of pairwise interactions with the other human genes/proteins from the TBEVHostDB. It was found that 41 human proteins (\~29%) had one or more pairwise interactions with the other human proteins (Additional file [1](#MOESM1){ref-type="media"}: Table S8). Among them, 29 proteins had one interaction with the other human proteins. Ten proteins had two interactions. And only two proteins (IFNAR1 and CCR5) had four interactions (with TYK2, PEPD, IFNB1, IFNA2 and CD4, CCL3, CCL4, CCL2, respectively) (Table [4](#Tab4){ref-type="table"}). The subnetworks formed by IFNAR1 and CCR5 and their first neighbors are presented in Fig. [2a and b](#Fig2){ref-type="fig"}.Table 4Genes/proteins from the TBEVHostDB that had four pairwise interactions with the other genes/proteins within the networkThe central gene/proteinDataset/Type of evidenceNumber of neighborsNeighborsBiological role of subnetworkIFNAR1Up- or down-regulated4TYK2, PEPD, IFNB1, IFNA2Attenuation of interferon signaling pathway by viral protein NS5 targeting PEPDCCR5Allelic variant4CD4, CCL3, CCL4, CCL2The entry of TBEV into the host cell/The proinflammatory and tissue damage pathway Fig. 2The subnetworks formed by human proteins with the maximal number of neighbors. Panel (A) IFNAR1 and its neighbors; Panel (B) CCR5 and its neighbors. The color legend is as described in Fig. [1](#Fig1){ref-type="fig"}

Discussion {#Sec10}
==========

A catalog of human genes involved in response to TBEV infection and the TBEVHostDB web resource {#Sec11}
-----------------------------------------------------------------------------------------------

The main objective of the present study was to obtain a systematic overview of human genes involved in response to TBEV infection. These genes may serve as clinical biomarkers for prediction of the TBEV infection course and outcome in humans. A systematic review of the literature revealed genes that were relevant to response to TBEV infection. As a result a catalog comprising 140 human genes was created (Table [1](#Tab1){ref-type="table"}, and Additional file [1](#MOESM1){ref-type="media"}: Tables S1-S6), and the TBEVHostDB web resource was designed. Thirty percent of genes from the TBEVHostDB (39 genes) were revealed from studies comparing TBEV-infected and uninfected human sera or other human biological samples (Table [3](#Tab3){ref-type="table"}). We did not find any analogs for such a comprehensive catalog of human genes relevant to response to TBEV infection. To date, genome-wide association studies have never been applied for identification of the genes associated with human genetic predisposition to TBE \[[@CR54]\]. The most recent review on genetic predisposition to diseases caused by flaviviruses presents nine human genes possessing allelic variants associated with severe forms of TBEV infection \[[@CR22]\]. The host cell response to tick-borne encephalitis virus was described recently \[[@CR55]\].

The other most comprehensive scientific report in this field described the knowledge base VirHostNet (<http://pbildb1.univ-lyon1.fr/virhostnet>) for the management and the analysis of proteome-wide virus-host interaction networks. To date, this knowledge base included data on 35 human genes encoding proteins involved in direct physical interactions with TBEV proteins \[[@CR56]\]. Thus, the TBEVHostDB web resource, created by manual curation of scientific publications, is the first effort of integrating and unifying data on genes/proteins involved in response to TBEV infection and genetic factors that may predispose to severe forms of diseases caused by TBEV.

Networks formed by associations between genes/proteins and ranking genes {#Sec12}
------------------------------------------------------------------------

At the next step, a network presenting pairwise interactions between TBEV particle itself, viral RNA and viral proteins and 140 genes/proteins from the TBEVHostDB was reconstructed (Fig. [1](#Fig1){ref-type="fig"}, Additional file [2](#MOESM2){ref-type="media"}). The network was formed by 173 interactions of seven types (Table [2](#Tab2){ref-type="table"}). Interactions of the first six types (*PIs involving TBEV, Up- or down-regulation, Associations, PPIs affecting response, Interaction within pathway, Knockout*) were obtained manually from the scientific publications. The data on physical interactions *PPI_STRING* involving human genes/proteins from the catalog was extracted from the STRING database \[[@CR36]\]. Thus, it allowed us to add additional 25 pairwise interactions involving 39 human genes/proteins within the network (Additional file [1](#MOESM1){ref-type="media"}: Table S7).

We ranked genes/proteins in the network according to the number of pairwise interactions and revealed two proteins (IFNAR1, CCR5) with the maximal number of interactions (each protein had four interactions) (Table [4](#Tab4){ref-type="table"}, and Additional file [1](#MOESM1){ref-type="media"}: Table S8). Thus, two subnetworks formed by these proteins and their closest neighbors (Fig. [2a](#Fig2){ref-type="fig"} and [b](#Fig2){ref-type="fig"}) were identified. A hypothesis on the functioning of subnetworks in the context of the host response to TBEV infection is as follows:

### IFNAR1 subnetwork {#Sec13}

IFNAR1 (interferon alpha and beta receptor subunit 1) had three direct physical interactions extracted from STRING (with tyrosine kinase 2 (*TYK2),* interferon beta 1 *(IFNB1),* interferon alpha 2 *(IFNA2*)) and one indirect interaction (*interaction within pathway*, extracted from the research article \[[@CR50]\]) with peptidase D (PEPD) (Fig. [2a](#Fig2){ref-type="fig"}). It is well known that all these five proteins (IFNAR1, TYK2*,* IFNB1, IFNA2, and PEPD) are involved in signal transduction pathway activating antiviral response (Interferon signaling cascade, Jak/STAT pathway) \[[@CR34], [@CR50], [@CR57]\]. In addition, two proteins TYK2 and PEPD had direct interactions with the viral NS5 protein \[[@CR30], [@CR50]\]. The expression levels of the other two genes/proteins (IFNB1, IFNA2) as well as IFNAR1 were changed in response to TBEV infection in humans and mice \[[@CR46], [@CR50], [@CR58]\]. Thus, we suggest that the subnetwork formed by NS5, from one hand, and IFNAR1, TYK2, IFNB1, IFNA2 and PEPD, from the other hand, represents the specific mechanism utilized by TBEV for interfering antiviral response of the host cell.

According to \[[@CR50]\] TBEV antagonism of the type I interferon signaling revealed PEPD as a regulator of IFNAR1 surface expression. NS5 derived from TBEV interacted with PEPD. In turn, PEPD is required for IFNAR1 maturation. This researcher proposed that PEPD might function in IFNAR1 biosynthesis by facilitating its trafficking through the ER-to-Golgi network \[[@CR50]\]. Thus NS5 binding to PEPD attenuates its activity, reducing IFNAR1 maturation and its expression on the cell surface.

On the other hand, a direct physical interaction between TBEV protein NS5 and the host tyrosine kinase 2 (TYK2) was identified \[[@CR30]\]. TYK2 associates with the cytoplasmic domain of type I and type II cytokine receptors and transmits cytokine signals by phosphorylating receptor subunits \[[@CR59]\]. We propose that protein-protein interactions between NS5 and TYK2 may serve as an additional mechanism leading to attenuation of interferon signaling.

### CCR5 subnetwork {#Sec14}

CCR5 had four direct physical interactions with CD4, CCL2, CCL3, and CCL4 (Fig. [2b](#Fig2){ref-type="fig"}). All four interactions were extracted from STRING and their reliability was checked manually by reviewing the literature. CCR5 encodes a cell surface receptor from the beta chemokine receptor family and is known to be an important co-receptor for a number of macrophage-tropic viruses including human immunodeficiency virus and simian immunodeficiency virus \[[@CR60]\].

On the other hand, CCL2/MCP1, CCL3/MIP-1-alpha, and CCL4/MIP-1-beta are C-C motif chemokine ligands, proinflammatory mediators interacting with C-C chemokine receptors (like CCR1, CCR2, CCR4), and CCR5 is among them \[[@CR60]\]. CD4 is a membrane glycoprotein, mediator of indirect neuronal damage in infectious and immune-mediated diseases of the central nervous system, which is able to form a complex with CCR5 in blood monocyte-derived dendritic cells \[[@CR61]\]. All four genes/proteins that were found to be involved in pairwise interactions with CCR5, were from *Up- or down-regulated* dataset. In particular, the expression of CCL4/MIP-1beta in primary human brain cortex astrocytes was upregulated in response to TBEV infection \[[@CR62]\]. Furthermore the levels of CD4, CCL2/MCP-1, CCL3/MIP-1alpha, CCL4/MIP-1beta mRNAs were increased in brains of BALB/c mice infected with TBEV \[[@CR63]\]. An excess release of proinflammatory mediators by the brain in response to TBEV infection may be the cause of tissue damage observed in encephalitis \[[@CR64]\].

The examination of the subnetwork formed by CD4, CCL2, CCL3, CCL4, and CCR5 leads to the hypothesis that the CCR5 allelic variant CCR5delta32 (rs333) may affect the TBE outcome not only affecting the entry of TBEV into the cell, but also modulating chemokine activity towards neural cells and CD4 glycoprotein functioning. In favor of this assumption are results obtained in mouse models: (1) in mice infected with West Nile virus, chemokine receptor CCR5 may promote leukocyte trafficking to the brain and host survival \[[@CR65]\]; (2) CCR5 enhances lymphocyte activation in mice infected with Japanese encephalitis virus, thereby promoting their survival \[[@CR66]\].

Pairwise interactions involving proteins from allelic variant dataset {#Sec15}
---------------------------------------------------------------------

Using the STRING database and subsequent manual curation of evidences confirming protein-protein interactions, we revealed 25 physical interactions involving 39 genes/proteins from the TBEVHostDB (Fig. [1](#Fig1){ref-type="fig"}, Additional file [1](#MOESM1){ref-type="media"}: Table S7). Four of these 39 genes/proteins were from the *Allelic variant* dataset. CCR5 which was revealed as a gene/protein with the maximal number of neighbors in the network was one of these four genes/proteins. In the previous section we proposed that Allelic variant CCR5delta32 in *CCR5* may modulate chemokine activity towards neural cells and CD4 glycoprotein functioning.

The other three genes/proteins from the *Allelic variant* dataset, which were involved in pairwise interactions, were *IL10*, *ARID1B*, and *IFNL3* (Fig. [1](#Fig1){ref-type="fig"}).

*IL10* encodes cytokine that was upregulated in brains of mice infected with TBEV \[[@CR63]\], as well as in the cerebrospinal fluid and in the serum of patients with TBE \[[@CR46]\]. The *IL10* allelic variant in promoter region (rs1800872) was associated with predisposition to TBE in Russian population \[[@CR15]\]. The protective role of IL10 against TBEV infection has been demonstrated in KO mice: knockout of *IL10* significantly increased mortality rates in mice infected with TBEV \[[@CR52]\]. Using STRING we found that IL10 interacted physically with alpha-2-macroglobulin (A2M) that was also found to be elevated in patients with the meningeal and focal forms of tick-borne encephalitis \[[@CR67]\]. Thus, the nucleotide substitution (rs1800872 locus) in the promoter of *IL10* may decrease expression level of interleukin 10, affecting its protective activity against pathological processes caused by TBEV.

*ARID1B* encodes AT-rich DNA interacting domain-containing protein functioning as a component of the SWI/SNF chromatin remodeling complex. From the STRING database we found that human ARID1B (UniProt ID = Q8NFD5) interacted physically with human SMARCB1/SNF5 (UniProt ID = Q12824) \[[@CR68]\]. In turn, SMARCB1/SNF5 interacted physically with ARID2/BAF200, and both proteins were found to be components of PBAF chromatin remodeling complex in Hela cells \[[@CR69]\]. Moreover, ARID2/BAF200 was required for selective expression of interferon-alpha-inducible genes \[[@CR69]\]. Basing on these observations we suggest that nucleotide substitution A- \> G (rs287886) in the first intron of *ARID1B* may mark a haplotype that included some exonic nonsynonymous nucleotide substitutions. In turn, substitutions of amino acids in ARID1B may disrupt or attenuate ability of this protein to interact with other components of the PBAF chromatin remodeling complex that may be crucial for interferon response.

*IFNL3/IL28B* is the fourth gene that had allelic variants associated with predisposition to TBE, and had an additional connection in the network (Fig. [1](#Fig1){ref-type="fig"}). *IFNL3/IL28B* was also contained in the *Up- or down-regulated* dataset. The associations of allelic variants in two polymorphic loci (rs8103142 and rs12980275) within *IFNL3/IL28B* with predisposition to TBE were revealed in the Russian population from Novosibirsk \[[@CR15]\]. Additionally, it was found in the Polish population that the level of IFNL3/IL28B in the cerebrospinal fluid of patients with TBE was significantly higher than in the control group \[[@CR46]\]. Based on this finding Grygorczuk S et al. assumed that IFNL3/IL28B might play a protective role in TBE. Thus, we suggest that rs12980275 locus in the IFNL3 3′-flanking region may impair transcriptional regulatory activity of this region that may lead to decreased *IFNL3/IL28B* expression. Ultimately, reduced levels of IFNL3/IL28B may influence the disease outcome.

The differences in severity of TBE may be caused by the different TBEV subtypes {#Sec16}
-------------------------------------------------------------------------------

The TBEVHostDB had been created as a catalog of human genes involved in response to TBEV infection. Thus, TBEVHostDB may be regarded as a database on genetic factors in humans that may potentially play a role in the severity of the disease. Besides this, an increasing number of studies show that the severity of the disease may be determined not only by genetic factors in humans, but also by genetic factors related to the virus subtypes.

As it was mentioned previously, three genetically distinct subtypes of viruses within a single TBE virus serocomplex cause TBE. These three subtypes consist of Far-Eastern subtype, Siberian subtype and European subtype. Each of these subtypes cause clinically distinct diseases with varying degrees of severity \[[@CR70]\]. TBEV of European subtype generally causes a biphasic disease, occasionally resulting in neurologic disease, but with a low case fatality rate. In contrast, infection by Far-Eastern subtype of TBEV is more frequently associated with severe neurologic disease, relatively high case fatality rate and an increased propensity for neurological sequelae in survivors. The Siberian subtype of TBEV is intermediate in disease severity, but has been associated with chronic infection \[[@CR4], [@CR70]\]. The experiments on animals confirm the opinion that different TBEV subtypes possess different pathogenic activities. First, colonized bank voles were infected by TBEV and the infection kinetics of all three known TBEV subtypes were studied. Throughout all time points post infection, RNA of the Far-Eastern TBEV was detected significantly more often than RNA of the other two strains in all organs studied \[[@CR71]\]. Second, the Siberian subtype of the TBEV was different from the Far-Eastern subtype by a moderate virulence observed in Siberian hamsters and by a low infection development rate \[[@CR72]\].

The relationship between the structure of the TBEV strains and their virulence or pathogenic properties had been studied for all three TBEV subtypes.

### European subtype {#Sec17}

In the study analyzing 72 TBE viruses of European subtype (sampled in Switzerland) the complete envelope (E) protein sequences were identified and phylogenetic classification was made out. Although all isolates were highly related (mean pairwise sequence identity of 97.8% at the nucleotide and 99.6% at the amino acid level of the E protein), more than half (57.8%) of isolates, that were characterized in vitro with respect to their plaque phenotype, produced a mixture of plaques of different sizes, reflecting a heterogeneous population of virus variants \[[@CR73]\].

In a mouse model the role of the poly(A) tract in the replication and virulence of TBEV strain of European subtype Torö-2003 was detected. The TBEV strain Torö-38A (containing modified (A)~3~C(A)~38~ sequence) replicated poorly compared to Torö-6A (containing the wild-type (A)~3~C(A)~6~ sequence) in cell culture, but Torö-38A was more virulent than Torö-6A in a mouse model of TBE \[[@CR74]\].

### Far-Eastern subtype {#Sec18}

Recently, complete genomes of 34 Far-Eastern subtype TBEV strains isolated from patients with different disease severity (Primorye, the Russian Far East) were sequenced and compared. It was found that the most pathogenic strains (causing encephalitic form of the disease) were divided into two branches: (1) including those related to the Sofjin strain (isolated in Russia, Primorye); (2) including Senzhang strain (isolated in northern China). Strains from patients with the subclinical form of TBE formed a third separate cluster, including the Oshima strain \[[@CR75]\].

The other two studies analyzing pathogenicity of the Far-Eastern subtype of TBEV (Sofjin-HO (highly pathogenic) and Oshima 5--10 (low pathogenic)) revealed the variable region of the 3' UTR as a critical virulence factor in a mouse model \[[@CR76], [@CR77]\].

Different pathogenic potentials of strains belonging to different clusters of phylogenetic tree based on complete genome sequencing of the Far-Eastern TBEV strains was revealed using a model of inbred mice of different ages \[[@CR78]\].

Pathologic potential of variant clones of the Oshima strain of Far-Eastern subtype of TBEV was analyzed in a separate study. It was shown that an amino acid substitution of Glu122 → Gly in the E protein could have affected virus infection and replication in vivo, as well as the attenuated pathogenicity in mice \[[@CR79]\].

Molecular mechanisms of interaction between human immune cells and Far Eastern TBEV strains (Dal'negorsk strain and Primorye-183 strain) were studied in vitro. The highly pathogenic Dal'negorsk strain penetrated into the blood cells more rapidly than Primorye-183 strain. Moreover, these two strains induced a significantly different changes of adhesion and activation receptors expression levels in monocytes and NK cells \[[@CR80]\].

### Siberian subtype {#Sec19}

The experimental infection caused in mice by two variants of one TBEV strain of Siberian subtype (strain EK-328 and variant 58, received from this strain population by cloning one plaque) was studied. The viruses differed from each other by three amino acids in the non-structural region (proteins NS2A and NS4A). It was found that these two strains differed in their effect on lymphocyte subpopulation structure of infected mice, providing different effects \[[@CR81]\].

Without claiming to be complete, this section indicates the need for accounting genetic factors related to the virus subtypes in predicting the severity of disease caused by TBEV infection.

Conclusion {#Sec20}
==========

It is known that susceptibility to infectious (and in particular, viral) diseases is a multifactorial trait, controlled by multiple genetic factors in combination with external environmental factors \[[@CR10], [@CR82]--[@CR85]\]. The identification of genes responsible for susceptibility/resistance of the host organism to TBEV infection is an ongoing challenge for modern molecular and medical genetics.

Due to the limited geographical distribution of ticks that carry TBEV (Central Europe, Baltic and Scandinavian countries, and the Russian Federation), the studies devoted to this problem are not numerous (in comparison to the number of studies focused on infections caused by the other viruses from the family *Flaviviridae* (Langat virus, Dengue virus, Japanese encephalitis virus, and, especially, hepatitis C virus)). However, given the fact that TBEV can cause severe infection in humans with a variety of neurological symptoms and diseases, the development of effective approaches to treatment of patients with TBE is crucial.

The evidence suggests that each virus species can interact with a unique set of proteins in the host cells \[[@CR30], [@CR86]\]. In accordance with this phenomenon, each virus species has developed its own countermeasures against immune response \[[@CR33]--[@CR35]\].

Based on these observations, it can be concluded that the data on the genes involved in response to other flaviviruses (even closely related to TBEV) do not fully relate to the mechanisms of TBEV interaction with host cell. Therefore, we focused on the task of collecting human genes revealed only in the context of response to TBEV.

As a result, the TBEVHostDB informational resource, comprising 140 human genes involved in response to TBEV infection was created. The reconstruction and analysis of the network formed by pairwise interactions involving genes/proteins from the TBEVHostDB and TBE viral particle (or viral RNA, or viral proteins) enabled us (1) to rank genes according to the number of neighbors, and (2) to reveal two subnetworks with clear biological roles in the context of the response to TBEV infection. Based on research evidence found in the literature \[[@CR26], [@CR50]\] we inferred that the first subnetwork formed by IFNAR1 (central node) and TYK2, PEPD, IFNB1, and IFNA2 presents the attenuation of interferon response by TBEV. In addition, we suggested that the second subnetwork (CCR5 as the central node, and its neighbors - CD4, CCL3, CCL4, and CCL2) may be the fragment of the proinflammatory signaling pathway. In addition, potential mechanisms for participation of *CCR5*, *IL10*, *ARID1B*, and *IFNL3* (genes from *Allelic variant* dataset) in the host response to TBEV infection were suggested.

This study aimed to collate all of the previously-published work in this area. Identification and systemization of data on genes involved in the host response to TBEV infection is important for understanding the molecular mechanisms of the interaction of TBE virus with the human body, as well as for identifying individuals at high risk for subsequent individualization of preventive measures and medical treatment. Beyond that, despite the fact that currently there is a human TBEV vaccine available, actually there is no specific treatment once infected. Hence, compiling genes and proteins involved in response to TBEV infection may provide grounds for the development of new therapeutics, which is one of the major concerns of TBEV research.
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